Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology, and Clinical Chemistry, University of Tübingen, 72076 Tübingen, Germany.
J Clin Endocrinol Metab. 2012 Dec;97(12):E2288-92. doi: 10.1210/jc.2012-2152. Epub 2012 Sep 26.
Increased hepatic de novo lipogenesis (DNL) in response to dietary sugar is implicated in the pathophysiology of fatty liver. Saturated fatty acids are the product of DNL and exert lipotoxic effects that promote liver fat accumulation. Desaturation of fatty acids by stearoyl-CoA desaturase 1 (SCD1) can prevent these deleterious effects. Here we investigated whether DNL and SCD1 are activated in parallel by dietary sugar and influence liver fat accumulation.
In 20 healthy subjects (eight females and 12 males, aged 30.5 ± 2.0 yr, body mass index 25.9 ± 0.5 kg/m(2)) who received a 4-wk lipogenic diet supplemented with 150 g/d of monosaccharides, hepatic SCD1 activity and DNL were determined using validated fatty acid ratios (16:1n-7/16:0; 16:0/18:2n-6) in very low-density lipoprotein triglycerides. Liver fat content was measured by localized (1)H-magnetic resonance spectroscopy.
At baseline, liver fat content was positively associated with the DNL (r = 0.54, P = 0.01) but not the SCD1 activity index (r = 0.16, P = 0.49). Dietary sugar supplementation increased liver fat content and DNL and SCD1 activity indices (+33, +19, and +8%, respectively). The increase of the DNL index was strongly related to the changes in liver fat content during the sugar supplementation (r = 0.75, P = 0.0001) but showed no association with changes in the SCD1 activity (P > 0.35). After the monosaccharide supplementation, the DNL index was still positively associated with liver fat content (r = 0.52, P = 0.02), whereas SCD1 activity showed a strong negative correlation with liver fat content (r = -0.63, P = 0.002).
DNL is closely linked with hepatic steatosis under dietary conditions rich in monosaccharides. Our data suggest that the individual hepatic SCD1 activity is a determinant of liver fat accumulation under lipogenic dietary conditions.
饮食中的糖会引起肝内从头合成脂肪酸(DNL)增加,这与脂肪肝的病理生理学有关。饱和脂肪酸是 DNL 的产物,发挥脂毒性作用,促进肝脏脂肪堆积。硬脂酰辅酶 A 去饱和酶 1(SCD1)使脂肪酸去饱和可以防止这些有害作用。在这里,我们研究了饮食中的糖是否会平行激活 DNL 和 SCD1,并影响肝脏脂肪堆积。
在 20 名健康受试者(8 名女性和 12 名男性,年龄 30.5 ± 2.0 岁,体重指数 25.9 ± 0.5kg/m2)中,给予富含 150g/d 单糖的 4 周生脂饮食,用验证的脂肪酸比值(16:1n-7/16:0;16:0/18:2n-6)在极低密度脂蛋白甘油三酯中测定肝 SCD1 活性和 DNL。通过局部(1)H 磁共振波谱法测量肝内脂肪含量。
在基线时,肝内脂肪含量与 DNL(r = 0.54,P = 0.01)呈正相关,但与 SCD1 活性指数(r = 0.16,P = 0.49)无关。饮食中添加糖后,肝内脂肪含量和 DNL 及 SCD1 活性指数分别增加(+33、+19 和+8%)。DNL 指数的增加与糖补充期间肝内脂肪含量的变化密切相关(r = 0.75,P = 0.0001),但与 SCD1 活性的变化无关(P>0.35)。在单糖补充后,DNL 指数仍与肝内脂肪含量呈正相关(r = 0.52,P = 0.02),而 SCD1 活性与肝内脂肪含量呈强负相关(r = -0.63,P = 0.002)。
在富含单糖的饮食条件下,DNL 与肝内脂肪沉着密切相关。我们的数据表明,个体肝 SCD1 活性是生脂饮食条件下肝内脂肪堆积的决定因素。